Mayne Pharma Group Limited (ASX:MYX)

Mayne Pharma Group Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash & Equivalents	80	59.84	110.07	92.62	96.67
Short-Term Investments	-	40.56	39.21	127.53	-
Trading Asset Securities	-	-	-	-	1.33
Cash & Short-Term Investments	80	100.4	149.28	220.14	98.01
Cash Growth	-20.32%	-32.74%	-32.19%	124.62%	0.03%
Accounts Receivable	157.15	164.62	176.47	177.4	259.72
Other Receivables	18.48	17.28	31.21	32.12	23.3
Receivables	175.63	181.9	207.68	209.52	283.02
Inventory	55.49	50.56	74.63	82.7	108.91
Prepaid Expenses	24.54	16.37	19.2	13.1	11.57
Restricted Cash	2.25	2.37	2.32	9.1	0.41
Other Current Assets	1.57	1.19	7.49	19.08	9.71
Total Current Assets	339.48	352.79	460.59	553.63	511.62
Property, Plant & Equipment	55.11	58.87	53.33	51.48	225.86
Goodwill	-	-	-	-	22.13
Other Intangible Assets	460.11	542.11	567.86	615.23	396.32
Long-Term Deferred Tax Assets	37.22	41.76	45.34	22.66	118.49
Long-Term Deferred Charges	2.94	3.67	0.72	2.04	9.07
Other Long-Term Assets	14.59	15.41	15.34	2.32	4.45
Total Assets	909.45	1,015	1,143	1,247	1,288

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Accounts Payable	25.26	30.25	20.87	32.03	63.57
Accrued Expenses	160.85	140.41	179.85	195.87	113.19
Short-Term Debt	-	-	-	10.81	405.37
Current Portion of Long-Term Debt	39.05	35.15	31.64	-	-
Current Portion of Leases	2.59	3.46	3.82	3.62	2.63
Current Income Taxes Payable	-	-	-	-	1.22
Other Current Liabilities	32.18	51.73	109.39	68.64	43.33
Total Current Liabilities	259.94	261.01	345.58	310.96	629.31
Long-Term Debt	-	-	-	28.48	-
Long-Term Leases	1.55	2.66	3.36	4.6	5.67
Pension & Post-Retirement Benefits	0.54	0.46	0.33	0.3	0.28
Long-Term Deferred Tax Liabilities	4.89	8.8	7.35	7.8	6.03
Other Long-Term Liabilities	251.6	371.4	332.37	260.86	108.4
Total Liabilities	518.51	644.32	688.99	612.99	749.7

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Common Stock	1,230	1,226	1,224	1,234	1,239
Retained Earnings	-1,017	-1,041	-944	-769.77	-840.35
Comprehensive Income & Other	177.68	185.29	173.97	170.44	147.7
Total Common Equity	390.94	370.28	454.19	634.36	545.88
Minority Interest	-	-	-	-	-7.65
Shareholders' Equity	390.94	370.28	454.19	634.36	538.23
Total Liabilities & Equity	909.45	1,015	1,143	1,247	1,288

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Total Debt	43.2	41.27	38.82	47.51	413.67
Net Cash (Debt)	36.81	59.13	110.46	172.64	-315.66
Net Cash Growth	-37.76%	-46.47%	-36.02%	-	-
Net Cash Per Share	0.35	0.75	1.39	2.10	-3.84
Filing Date Shares Outstanding	81.25	81.25	81.25	83.42	88.24
Total Common Shares Outstanding	81.25	81.25	81.25	83.42	88.24
Working Capital	79.54	91.78	115.01	242.67	-117.69
Book Value Per Share	4.81	4.56	5.59	7.60	6.19
Tangible Book Value	-69.17	-171.82	-113.67	19.14	127.44
Tangible Book Value Per Share	-0.85	-2.11	-1.40	0.23	1.44
Land	2.98	2.98	2.98	2.98	8.1
Buildings	24.6	19.92	19.92	19.92	128.95
Machinery	71.68	63.69	60.62	65.59	184.83
Construction In Progress	3.69	14.04	6.63	-0.01	11.18

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 1, 2026

Data Sources Report a data error